145 related articles for article (PubMed ID: 10804024)
1. Selective drug delivery system to bone: small peptide (Asp)6 conjugation.
Kasugai S; Fujisawa R; Waki Y; Miyamoto K; Ohya K
J Bone Miner Res; 2000 May; 15(5):936-43. PubMed ID: 10804024
[TBL] [Abstract][Full Text] [Related]
2. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems.
Wang D; Miller S; Sima M; Kopecková P; Kopecek J
Bioconjug Chem; 2003; 14(5):853-9. PubMed ID: 13129387
[TBL] [Abstract][Full Text] [Related]
4. Osteotropic Peptide that differentiates functional domains of the skeleton.
Wang D; Miller SC; Shlyakhtenko LS; Portillo AM; Liu XM; Papangkorn K; Kopecková P; Lyubchenko Y; Higuchi WI; Kopecek J
Bioconjug Chem; 2007; 18(5):1375-8. PubMed ID: 17705416
[TBL] [Abstract][Full Text] [Related]
5. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
6. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
7. A selective reaction of fructose bisphosphate aldolase with fluorescein isothiocyanate in chicken muscle extracts.
Gehring AG; Ezzell JL; Lebherz HG
J Mol Recognit; 2008; 21(3):137-47. PubMed ID: 18438970
[TBL] [Abstract][Full Text] [Related]
8. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
[TBL] [Abstract][Full Text] [Related]
9. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
10. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells.
Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A
Biomaterials; 2006 Sep; 27(25):4428-33. PubMed ID: 16682075
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorescein isothiocyanate- and Texas red-conjugated nucleotides for direct labeling in comparative genomic hybridization.
Larramendy ML; El-Rifai W; Knuutila S
Cytometry; 1998 Mar; 31(3):174-9. PubMed ID: 9515716
[TBL] [Abstract][Full Text] [Related]
12. Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease.
Shi Y; Su Z; Li S; Chen Y; Chen X; Xiao Y; Sun M; Ping Q; Zong L
Mol Pharm; 2013 Jun; 10(6):2479-89. PubMed ID: 23646913
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of FITC near stratum corneum-visualizing epidermal distribution of a strong sensitizer using two-photon microscopy.
Samuelsson K; Simonsson C; Jonsson CA; Westman G; Ericson MB; Karlberg AT
Contact Dermatitis; 2009 Aug; 61(2):91-100. PubMed ID: 19706049
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry.
Liu CZ; Wang YW; Shen MC; Huang TF
Thromb Haemost; 1994 Dec; 72(6):919-25. PubMed ID: 7740464
[TBL] [Abstract][Full Text] [Related]
15. Chromatographic analysis of lysosomal degradation of unlabeled native proteins in vitro by fluorescein isothiocyanate labeling.
Ohshita T
Anal Biochem; 1993 Nov; 215(1):17-23. PubMed ID: 8297010
[TBL] [Abstract][Full Text] [Related]
16. BSA-FITC-loaded microcapsules for in vivo delivery.
Kim BS; Oh JM; Kim KS; Seo KS; Cho JS; Khang G; Lee HB; Park K; Kim MS
Biomaterials; 2009 Feb; 30(5):902-9. PubMed ID: 19027943
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
[TBL] [Abstract][Full Text] [Related]
18. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
19. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats.
Jani PU; Nomura T; Yamashita F; Takakura Y; Florence AT; Hashida M
J Drug Target; 1996; 4(2):87-93. PubMed ID: 8894968
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary screening and identification of a peptide that binds specifically to gastric cancers cells with high metastasis to peritoneum].
Bai FH; Wang J; Zhao PT; Cao SS; Lei T; Li Y; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):659-63. PubMed ID: 16681920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
